Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • NVO vs GSK✓SelectedUSD · GSKNVO vs GSK performance historyLatest closeAs of-3.12%11/18
Stock and ETF performance explorer

NVO vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-23.1%
GSK return
+42.7%
Excess return
-65.8%
Maximum drawdown
-74.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.1%-1.3%-1.8%-2.6%
7D-4.0%-3.1%-0.9%-2.8%
30D+2.6%-0.9%+3.5%+3.0%
3M-13.7%-4.2%-9.6%-12.3%
6M-9.8%-1.6%-8.2%-9.3%
YTD-18.6%+2.6%-21.2%-20.7%
1Y-12.9%+6.2%-19.2%-16.4%
3Y-57.6%+55.0%-112.5%-66.1%
5Y-23.1%+42.8%-66.0%-44.6%
All-23.1%+42.7%-65.8%-44.6%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling